Harvest Portfolios Group Inc. Eli Lilly & CO Transaction History

Harvest Portfolios Group Inc.

$3.37 Billion
Q1 2025

A detailed history of Harvest Portfolios Group Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Harvest Portfolios Group Inc. holds 126,155 shares of LLY stock, worth $95.3 Million. This represents 3.09% of its overall portfolio holdings.

Number of Shares

126,155

Previous 122,892 2.66%

Holding current value

$95.3 Million

Previous $94.9 Million 9.82%

% of portfolio

3.09%

Previous 3.18%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$725.72 - $929.72 $2.37 Million - $3.03 Million	3,263 Added 2.66%	126,155 $104 Million
Q4 2024 Feb 14, 2025	BUY	$727.2 - $932.06 $26.6 Million - $34.1 Million	36,587 Added 42.39%	122,892 $94.9 Million
Q3 2024 Oct 30, 2024	BUY	$772.14 - $960.02 $15.6 Million - $19.3 Million	20,146 Added 30.45%	86,305 $76.5 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $658,181 - $825,408	-908 Reduced 1.35%	66,159 $59.9 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $15.6 Million - $20.8 Million	-26,289 Reduced 28.16%	67,067 $52.2 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.37 Million - $1.61 Million	-2,600 Reduced 2.71%	93,356 $54.4 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $7.27 Million - $10 Million	-16,719 Reduced 14.84%	95,956 $51.5 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $15.7 Million - $21 Million	-44,842 Reduced 28.47%	112,675 $52.8 Million
Q1 2023 May 18, 2023	BUY	$310.63 - $364.82 $9.62 Million - $11.3 Million	30,969 Added 24.47%	157,517 $54.1 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $40.7 Million - $47.4 Million	126,548 New	126,548 $0

Others Institutions Holding LLY

# of Institutions

4,371

Shares Held

820M

Call Options Held

9.47M

Put Options Held

11.3M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $718B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Portfolios Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harvest Portfolios Group Inc. with notifications on news.

Account

Harvest Portfolios Group Inc. Eli Lilly & CO Transaction History